Clinical trials
Terminated Phase 2 Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Merck KGaA, Darmstadt, Germany | 2 |
| Novartis Pharmaceuticals | 2 |
| Boston Scientific Corporation | 1 |
| Charite University, Berlin, Germany | 1 |
| Clene Nanomedicine | 1 |
| EMD Serono | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| GeNeuro SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 19 |
| Multiple Sclerosis | 6 |
| Demyelinating Diseases | 3 |
| Autoimmune Diseases | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Immune System Diseases | 1 |
| Nervous System Diseases | 1 |
| Neuritis | 1 |
| Optic Nerve Diseases | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.